×

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride

  • US 9,108,961 B2
  • Filed: 02/19/2014
  • Issued: 08/18/2015
  • Est. Priority Date: 05/17/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method of improving cognition in a patient suffering from Schizophrenia, comprising administering to the patient a crystalline Form I of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×